These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24844698)

  • 21. Fecal microbiota transplantation for treating recurrent Clostridium difficile infection.
    Manag Care; 2013 Jun; 22(6):18-9. PubMed ID: 23841136
    [No Abstract]   [Full Text] [Related]  

  • 22. Letter: Faecal microbiota transplantation--not a one-size-fits-all approach.
    Ianiro G; Gasbarrini A; Cammarota G
    Aliment Pharmacol Ther; 2014 Jul; 40(1):119. PubMed ID: 24903435
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter: Faecal microbiota transplantation--not a one-size-fits-all approach; authors' reply.
    Sha S; Wu K
    Aliment Pharmacol Ther; 2014 Jul; 40(1):119-20. PubMed ID: 24903434
    [No Abstract]   [Full Text] [Related]  

  • 24. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?
    Damman CJ; Miller SI; Surawicz CM; Zisman TL
    Am J Gastroenterol; 2012 Oct; 107(10):1452-9. PubMed ID: 23034604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal microbiota transplantation: past, present and future.
    Aroniadis OC; Brandt LJ
    Curr Opin Gastroenterol; 2013 Jan; 29(1):79-84. PubMed ID: 23041678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal microbiota transplantation: facts and controversies.
    van Nood E; Speelman P; Nieuwdorp M; Keller J
    Curr Opin Gastroenterol; 2014 Jan; 30(1):34-9. PubMed ID: 24241245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal microbiota transplantation and emerging treatments for Clostridium difficile infection.
    Gens KD; Elshaboury RH; Holt JS
    J Pharm Pract; 2013 Oct; 26(5):498-505. PubMed ID: 23966282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recurrent Clostridium difficile infections: the importance of the intestinal microbiota].
    Zanella Terrier MC; Frossard JL; Simonet ML
    Rev Med Suisse; 2013 Oct; 9(402):1898, 1900-4. PubMed ID: 24298714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal microbiota transplantation for treatment of recurrent C. difficile infection.
    Clin Privil White Pap; 2013 Aug; (246):1-15. PubMed ID: 24133730
    [No Abstract]   [Full Text] [Related]  

  • 30. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection.
    De Leon LM; Watson JB; Kelly CR
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1036-8. PubMed ID: 23669309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile infection and inflammatory bowel disease.
    Musa S; Thomson S; Cowan M; Rahman T
    Scand J Gastroenterol; 2010 Mar; 45(3):261-72. PubMed ID: 20025557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faecal microbiota transplantation: a sui generis biological drug, not a tissue.
    Megerlin F; Fouassier E; Lopert R; Bourlioux P
    Ann Pharm Fr; 2014 Jul; 72(4):217-20. PubMed ID: 24997882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies.
    Shanahan F; Quigley EM
    Gastroenterology; 2014 May; 146(6):1554-63. PubMed ID: 24486051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal microbiota transplantation for recurrent clostridium difficile infection.
    Brandt LJ; Reddy SS
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S159-67. PubMed ID: 21992957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stool transplantation for older patients with Clostridium difficile infection.
    Rubin TA; Gessert CE; Aas J
    J Am Geriatr Soc; 2009 Dec; 57(12):2386. PubMed ID: 20122011
    [No Abstract]   [Full Text] [Related]  

  • 36. Review article: faecal transplantation therapy for gastrointestinal disease.
    Landy J; Al-Hassi HO; McLaughlin SD; Walker AW; Ciclitira PJ; Nicholls RJ; Clark SK; Hart AL
    Aliment Pharmacol Ther; 2011 Aug; 34(4):409-15. PubMed ID: 21682755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile and Clostridium perfringens species detected in infant faecal microbiota using 16S rRNA targeted probes.
    Fallani M; Rigottier-Gois L; Aguilera M; Bridonneau C; Collignon A; Edwards CA; Corthier G; Doré J
    J Microbiol Methods; 2006 Oct; 67(1):150-61. PubMed ID: 16647148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection.
    Brandt LJ
    Am J Gastroenterol; 2013 Feb; 108(2):177-85. PubMed ID: 23318479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physician attitudes toward the use of fecal transplantation for recurrent Clostridium difficile infection in a metropolitan area.
    Jiang ZD; Hoang LN; Lasco TM; Garey KW; Dupont HL
    Clin Infect Dis; 2013 Apr; 56(7):1059-60. PubMed ID: 23223589
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of Clostridium difficile infection.
    Meyers S
    Mt Sinai J Med; 1995 May; 62(3):183-7. PubMed ID: 7616972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.